Close Menu

An epigenomic analysis of neurons from Parkinson's disease patients reveals that the loss of TET2, a master regulator of cytosine modification status, can help protect the brain from the effects of the disease. In the study, which appears in Nature Neuroscience, Van Andel Institute scientists performed a genome-wide analysis of DNA methylation and hydroxymethylation at enhancers in neurons from Parkinson's disease patients and controls.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.